Sponsor or institution
Clinical trials and research at Bambusa Therapeutics
As of November 12, 2026, Find a Trial lists 6 clinical trials run by Bambusa Therapeutics that are recruiting, at sites in 6 countries (most in China (4), Australia (2), New Zealand (2)). By phase: Phase 1 (4), Phase 1/2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 6Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| BBT001 in adults with chronic spontaneous urticaria | Phase 1/2 | Wuhu, Anhui and 9 other locations | Recruiting | Jul 21, 2026 |
| BBT002 in healthy adults and in people with chronic rhinosinusitis with nasal polyps | Phase 1/2 | Beijing, Beijing Municipality and 11 other locations | Recruiting | Feb 27, 2026 |
| BBT002 in healthy adults and adults with COPD | Phase 1 | Hefei, Anhui and 10 other locations | Recruiting | Dec 17, 2025 |
| BBT001 in healthy adults and adults with moderate to severe atopic dermatitis | Phase 1 | Hefei, Anhui and 9 other locations | Recruiting | Nov 20, 2025 |
| Evaluating BBT002 in Healthy Volunteers and COPD Patients | Phase 1 | Bowling Green, Kentucky and 13 other locations | Recruiting | Apr 25, 2025 |
| Testing BBT001 in healthy volunteers and adults with atopic dermatitis | Phase 1 | Irvine, California and 13 other locations | Recruiting | Feb 5, 2025 |
All recruiting trials (6)
-
BBT001 in adults with chronic spontaneous urticaria
This trial tests whether BBT001 given by IV is safe and can help reduce urticaria in adults who have chronic spontaneous hives.
-
BBT002 in healthy adults and in people with chronic rhinosinusitis with nasal polyps
This study tests BBT002 versus placebo to see how it acts, how safe it is, and whether it helps people with chronic rhinosinusitis with nasal polyps, with or without asthma.
-
BBT002 in healthy adults and adults with COPD
This tests BBT002 versus placebo in healthy adults and people with COPD to see if it is safe and how the body responds to it.
-
BBT001 in healthy adults and adults with moderate to severe atopic dermatitis
This trial tests whether single and repeated doses of BBT001 are safe and well tolerated in healthy adults and in adults with moderate to severe atopic dermatitis.
-
Evaluating BBT002 in Healthy Volunteers and COPD Patients
This study is testing a new drug called BBT002 in healthy volunteers and COPD patients to see how safe it is and how well it works.
-
Testing BBT001 in healthy volunteers and adults with atopic dermatitis
This study is testing a new drug called BBT001 in healthy people and adults with atopic dermatitis to see if it's safe and effective.
Quick answers
How many clinical trials run by Bambusa Therapeutics are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in China (4 trials), Australia (2 trials), New Zealand (2 trials), Poland (2 trials), United States (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 4, Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.